PHARMATECA » Search Articles by Keyword

Found: 38 articles

Article	Edition
Vladimirova I.S., Kruglova L.S. Psoriasis of special localizations and the effectiveness of the IL-23 inhibitor guselkumab in clinical practice	№10 / 2024
Olkhovskaya K.B., Kruglova L.S. Empirical therapy of inflammatory dermatoses	№10 / 2024
Gaydina T.A., Munzalevskaya Yu.D., Silin A.A. Interdisciplinary approach to prevention of otitis externa recurrence in patients with underlying dermatological diseases	№10 / 2024
Svechnikova E.V., Zhufina S.E. Prevalence of chronic kidney disease in patients with psoriasis: place of genetic engineering biological therapy	№5 / 2024
Evdokimov E.Yu., Svechnikova E.V., Ponezheva Zh.B. The role of psoriasis in systemic inflammation in HIV-infected patients and the importance of biological therapy	№5 / 2024
Shulepov V.V., Novikov Yu.A., Pravdina O.V. Review of innovative methods of therapy for psoriasis	№5 / 2024
Vereshchagin E.I., Svechnikova E.V., Maksimova Yu.V., Arutyunyan G.B., Artemyeva N.O., Devyatova A.V. Hyperuricemia as a marker of chronic systemic inflammation in the pathogenesis of psoriasis	№5 / 2024
A.A. Martynov, A.V. Vlasova, O.S. Mishina, G.V. Lukyanova Social characteristics of russian patients with psoriasis and arthropathic psoriasis	№13 / 2023
Sh.Kh.R. Sarsur, N.S. Rudneva Results of comparison of the effectiveness of adalimumab and ixekizumab in the treatment of psoriasis	№13 / 2023
N.O. Pereverzina, L.S. Kruglova Personalized approach to the treatment of patients with skin psoriasis and inflammatory back pain, taking into account comorbid pathology	№13 / 2023
S.F. Alyavi, A.B. Rakhmatov Importance of the nitric oxide system in the development of psoriasis	№8 / 2023
I.S. Vladimirova Psoriasis, metabolic syndrome and COVID-19: a case report	№14 / 2022